Vanguard Report: Inequality and antibiotic resistance

  04 July 2021

COVID-19 has focused global attention on the inequitable access to tools needed to mitigate a pandemic, with high-income countries (HICs) and low- and middle-income countries (LMICs) at opposite ends of the scale. In the case of antibiotic resistance, a pandemic projected to cause 4 times more deaths per year than occurred from COVID-19 during 2020, inequity also reigns supreme – lack of access to antibiotics in some poorer countries, a driver of mortality particularly in children under 5 years of age, lack of access to newer, expensive antibiotics needed to treat the increasing toll of multi- and extensively-resistant bacterial infections, and lastly and most importantly, the inequity in ability to provide the basic public health interventions that drive many of the social determinants of infectious diseases in LMICs.

Further reading: BSAC
Author(s): Marc Mendelson
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!